Last reviewed · How we verify
The Effects of Nebivolol on the NO-system in Patients With Essential (NEBI)
Investigators want investigate the following hypothesis: 1. Nebivolol increases nitric oxide activity in the systemic circulation and the kidney 2. The increased activity of nitric oxide during nebivolol treatment can be demonstrated by inhibition of NO synthesis with L-NMMA. We expect increased responses in blood pressure and sodium excretion is expected during nebivolol treatment compared to placebo.
Details
| Lead sponsor | Erling Bjerregaard Pedersen |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 25 |
| Start date | 2012-08 |
| Completion | 2013-09 |
Conditions
- Essential Hypertension
Interventions
- Nebivolol
- placebo
Primary outcomes
- Fractional excretion of sodium — 5 days
Countries
Denmark